Warning letters: Same old, same old at FDA
Regulatory NewsJoanne S. Eglovitch
Advanced therapies/cell and gene therapyAudit/inspectionBiologics/ biosimilars/ vaccinesBiotechnologyComplianceQuality Assurance and ControlRegulatory Intelligence/PolicyUnited States